NeurAxis Announces Publication Of Medical Policy Coverage For Percutaneous Electrical Nerve Field Stimulation With A Blue Cross Blue Shield License In FL

NeurAxis Announces Publication Of Medical Policy Coverage For Percutaneous Electrical Nerve Field Stimulation With A Blue Cross Blue Shield License In FL

BenzingaMay 16 08:07

NeurAxis Announces New Medical Policy Coverage For Nearly Six Million Lives in Florida

Globe NewswireMay 16 08:00

NeurAxis to Host First Quarter 2024 Results and Business Update Call on Wednesday, May 22, 2024

CARMEL, Ind., May 15, 2024 (GLOBE NEWSWIRE) -- NeurAxis, Inc. ("NeurAxis," or the "Company") (NYSE:NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating

GlobeNewswireMay 15 15:30

NeurAxis Announces New Medical Policy Coverage in North Dakota

CARMEL, Ind., April 23, 2024 (GLOBE NEWSWIRE) -- NeurAxis, Inc. ("NeurAxis," or the "Company") (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressin

GlobeNewswireApr 23 08:00

Neuraxis (NRXS.US): The 2023 Q4 financial report achieved revenue of US$531.46 million, with an expected value of US$1.61 million; earnings per share of -0.85 US dollars.

Neuraxis (NRXS.US): The 2023 Q4 financial report achieved revenue of US$531.46 million, with an expected value of US$1.61 million; earnings per share of -0.85 US dollars.

Zhitong FinanceApr 16 18:10

NeurAxis, Inc. (NASDAQ:NRXS) Q4 2023 Earnings Call Transcript

Yahoo FinanceApr 12 07:44